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Abstract
Introduction: Chronic non-cancer pain is far reaching, affecting over 100 million Americans
(Zgierska et al., 2018). Opioids are commonly prescribed for chronic pain, with approximately
20% of patients presenting to primary care offices with symptoms of pain or pain-related
diagnoses (Dowell, Haegerich, & Chou, 2016). As a result, opioid prescribing rates are
increasing at a faster rate for primary care practice compared with other specialties (Dowell et
al., 2016). Within the United States population, it is estimated that three percent to four percent
of the adult population are prescribed long-term opioids for the treatment of chronic non-cancer
pain (Dowell et al., 2016). The use of opioid pain medication presents serious risks for patients
receiving them, including overdose and opioid use disorder (Dowell et al., 2016). Long-term use
of opioids for chronic pain is controversial and has been linked to dose-dependent harm,
addiction, overdose, and death (Zgierska et al., 2018). Approximately 85% of those who misuse
opioids obtain their main drug supply from opioid prescriptions (Zgierska et al., 2018). On the
basis of Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) criteria, it is
estimated that 1.9 million Americans abuse or are dependent on prescription opioids (Dowell et
al., 2016). Opioid-related deaths in the United States have increased dramatically, making this a
national public health crisis (Zgierska et al., 2018).
Objectives: The primary study objective is to assess whether evidence-based practice
guidelines are being followed regarding the care being delivered to opioid recipient patients.
Methods: This is a quality improvement project that will include a retrospective evaluation of
quality measures for evidence-based care being delivered to opioid recipients. This project
will occur at a primary care office that is part of a large mid-western healthcare system.
Resources needed for this project include access to patient charts located at the primary care
clinic, use of a laptop, space within the primary care clinic in which to work, and materials
needed to produce a toolkit. Additional resources include collaboration with the site mentor
and office manager, utilization of information technology (IT) personnel, and consultations
with a statistician. To be included in the analysis, patients must meet the following inclusive
criteria: age greater than or equal to 18 years old; active patient status (seen in the past three
years); have a primary care provider within this office; do not have a diagnosis of malignant
neoplasm or hospice status; and have at least one opioid prescription in the past 45 days that
was not prescribed for acute pain. Medical records will be reviewed for adult patients at the
primary care clinic who are currently prescribed opioids. Furthermore, medical records will be
assessed for quality measures of evidence-based care. Evidence-based action plans and a
toolkit will be presented and provided to the primary care office’s leaders, providers, and staff
to continue to improve measures reflecting organizational goals and measurement targets.
Results: Expected results include potential gaps of continual improvement in evidence-based
care that is being provided to patients in the primary care setting.
Conclusions: Expected conclusions include identified areas of quality measures for evidencebased care.
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Implications: Areas for practice change will be identified and strategies to improve quality
measures of care will be implemented. Patients receiving an opioid prescription will receive
evidence-based care leading to improvement in patient safety.
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Evaluation of Processes and Procedures for Care of the Opioid Recipient Patient in the Primary
Care Setting
Assessment and treatment of chronic pain has been a challenge for healthcare providers
and systems, as they have struggled to find a balance between effective treatment for chronic
pain and its potential for harm (Dowell et al., 2016). Primary care clinicians report having
concerns about prescribing opioids, feel they have had insufficient training in prescribing
opioids, and find managing patients with chronic pain stressful (Dowell et al., 2016). Clinicians
also report concerns about opioid medication misuse, addiction, and overdose (Dowell et al.,
2016). With increasing regulatory scrutiny at the federal and state levels surrounding opioid
misuse, primary care clinicians are less willing to manage chronic non-cancer pain with longterm opioid use (Jamison, Scanlan, Matthews, Jurcik, & Ross, 2016). Primary care clinicians
also report difficulty in following opioid prescription guidelines, citing lack of time for opioid
management practices (Becker, Merlin, Manhapra, & Edens, 2016).
In 2016, the Centers for Disease Control and Prevention (CDC) released guidelines for
prescribing opioids for chronic pain. The CDC conducted a clinical systematic review of the
scientific evidence to identify effectiveness, benefits, and harms of long-term opioid therapy for
chronic pain (Dowell et al., 2016). On the basis of this systematic review, the CDC developed
the guideline for prescribing opioids to treat chronic pain. Clinicians should use urine drug
testing before starting opioid therapy and at least annually to assess for prescribed medications,
other controlled substances, and illicit drugs (Dowell et al., 2016). Whenever possible, clinicians
should avoid prescribing opioids and benzodiazepines concurrently (Dowell et al., 2016). For
patients who are found to have opioid use disorder, clinicians should offer or arrange evidencebased treatment, usually with buprenorphine or methadone in combination with behavioral
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therapies (Dowell et al., 2016). Additionally, patients with chronic pain should be assessed for
depression, as this population is at a higher risk for developing depressive symptoms (Dowell et
al., 2016).
In Michigan, new laws have recently gone into effect and have been the catalyst for
change within the healthcare organization where this quality improvement project will take
place. Starting June 1st, 2018, all providers prescribing or dispensing a controlled substance were
required to be registered with Michigan Automated Prescription System (MAPS) in order to
remain compliant. In addition, starting June 1st, 2018, the prescriber must provide the following
information to the patient before prescribing an opioid:
•

The danger of opioid addiction

•

How to properly dispose of an expired, unused, or unwanted controlled substance

•

That the delivery of a controlled substance is a felony under Michigan Law

•

If the patient is pregnant or is a female of reproductive age, the short and long-term
effects of exposing a fetus to an opioid, including but not limited to neonatal abstinence
syndrome

After providing the information detailed above, the prescriber must obtain the signature of
the patient or the patient’s representative on a start talking consent form. The signed form must
be kept in the patient’s medical record. On July 1st, 2018, prescribers treating a patient for acute
pain could not prescribe more than a seven day supply of an opioid within a seven day period.
This information was disseminated to the primary care office via email communication with the
office manager. The office manager passed these materials to providers and office staff during
staff meetings.

9
PROPOSAL DEFENSE

Thus far, aside from the materials created by members of the organization’s opioid taskforce,
no initiatives have been made to review or evaluate quality of care processes provided to opioid
recipient patients. As evidence suggests, there are quality measures that should be part of how
care is provided to patients being treated for chronic pain. In many health care settings, part of
evaluating whether quality measures are being met involves implementation of quality
improvement projects. The purpose of this written discussion is to describe a proposed evidencebased quality improvement project that addresses standards of care for opioid recipient patients,
in partial fulfillment of the Doctor of Nursing Practice degree. The assessment of the
organization will be discussed, along with evidence that was gathered during a literature review.
In addition, the project plan will be described in depth.
Assessment of the Organization
This Midwestern health system is a non-profit healthcare organization that is part of a
larger over-arching multi-institutional Catholic health system, which is sponsored by Catholic
Health Ministries (XXX, 2018). Becoming part of a larger entity occurred recently and has made
this healthcare system part of the second largest Catholic healthcare system in the nation (XXX,
2018). Within the West Michigan area, there are a total of 33 primary care offices that are part of
the health system (XXX, 2018). To assess the organization, the Burke and Litwin Model of
Organizational Performance and Change was utilized to explore the current needs within the
organization and opportunities for change. Additionally, an assessment of the strengths,
weaknesses, opportunities, and threats (SWOT) was completed to further analyze the identified
problem. In combination, these two tools will serve as a platform for the completion of a doctoral
nursing scholarly project.
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Framework for Assessment
The Burke and Litwin Model of Organizational Performance and Change was created to
provide a guide for organizational diagnosis and manage organizational change (Burke & Litwin,
1992). The model is used to help assess organizational and environmental factors, and how these
dimensions should be linked to achieve change in performance or practice (Burke & Litwin,
1992). The model revolves around 12 organizational factors that interact together and affect one
another (Appendix A). Burke and Litwin (1992) state that the two distinct variables within an
organization are climate and culture. Climate can be defined in terms of organizational members’
perceptions, whereas culture can be defined in terms of values and beliefs (Burke & Litwin,
1992). Within the model, there are variables that influence and are influenced by climate, and
variables that are influenced by culture (Burke & Litwin, 1992). The variables that define
organizational climate are transactional factors, and the variables that define culture are
transformational factors (Burke & Litwin, 1992).
Transformational factors are considered the most influential forces of change and include
the external environment, mission and strategy, leadership, organizational culture, and individual
and organizational performance (Burke & Litwin, 1992). Burke and Litwin (1992) state that of
those factors, external environment is arguably the most persuasive factor to drive change.
Transformational factors require analysis at the organization’s macro level in order to identify
which organizational dimensions need to be highlighted during the change process (Burke &
Litwin, 1992).
Transactional factors are the structural pieces of the work climate and consist of
exchanges among members of the organization (Burke & Litwin, 1992). The transactional
factors explain reciprocity among people and groups for mutual gain (Burke & Litwin, 1992).
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Transactional factors include management practices, structure, systems, work climate, tasks and
individual skills, motivations, individual needs and values, and individual and organizational
performance (Burke & Litwin, 1992).
Ethics and Protection of Human Subjects
An application for review and approval or exemption of this project will be submitted to
the health care system’s Institutional Review Board and to Grand Valley State University. Aside
from project planning, no project activities will commence until the review is completed and
Board approval or exemption is granted. The purpose and scope of this project are limited to
evidence-based practice improvement or quality improvement. No patient identifiable
information will be collected. There are no physical, social, psychological, legal, or economic
threats to patients in association with this project. The impact of the project will pose no risk to
participants. All members of the project team have completed human subject protection training
via the Collaborative Institute Training Initiative and their actions will be guided accordingly.
Stakeholders
Key stakeholders in standards of care for opioid recipient patients include the leaders of
the healthcare organization, healthcare providers (physicians, nurse practitioners, physician
assistants), nursing staff (registered nurse and licensed practical nurses), medical assistants,
office leaders (office manager, office practice leader for physicians, office practice leader for
nursing), pharmacists, and patients. Leaders of the healthcare organization are committed to
providing the highest level of care to opioid recipient patients, as evidenced by the creation of
the opioid taskforce. The healthcare providers who care for and prescribe to opioid recipient
patients are committed to patient safety and providing evidence-based care, as evidenced by
enacting new initiatives put for by the physicians from the opioid taskforce. This includes
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providing treatment forms, consent forms, and documenting that MAPS has been checked.
Nurses and medical assistants work in tandem with the providers to care for the patient, assist
with documentation, and assist with prescription re-fills. Pharmacists ultimately fill medications
and deliver them to patients. Office leaders guide change management practices and are therefore
key stakeholders. At the center of the stakeholder ring lies the patient, who represents the most
important stakeholder. Patients who experience chronic pain and receive opioid prescriptions as
treatment have the greatest vested interest in the care they receive from the healthcare
organization.
Strength, Weakness, Opportunity, Threat Analysis
The Strength, Weakness, Opportunity, Threat (SWOT) analysis is a tool used to look at
the settings internal strengths and weaknesses, and external opportunities and threats that
ultimately help or hinder an organization’s project for change (Moran et al., 2017). For this
SWOT analysis, the focus is on the primary care office, yet the organization as a whole will be
considered in the context of external opportunities and threats (Appendix B). The SWOT
analysis was completed in tandem with the organizational assessment and provided structure for
evaluating the primary care clinic and the organization as a whole.
Strengths. Identified organizational strengths include affiliation with a larger health system.
Being part of a larger health system allows access to many resources, both financially and in
regard to professional talent and knowledge. The opioid taskforce is representative of pooling
talent within a large organization. The opioid taskforce is a group of physicians that are
passionate about the opioid epidemic and feel changes within the organization are needed.
Having this taskforce in place represents a significant strength for the organization as a whole,
and for projects that address opioids.
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Staff members are committed to the organization’s mission and strategy and are therefore
willing to change in order to improve care for patients. The environment is team-based and
everyone strives to work cohesively. The majority of staff members at the primary care clinic are
also flexible and open to new ideas.
Other strengths include management and practice lead physician buy in for changes
regarding the care of opioid recipient patients. The office manager and practice lead physician of
this primary care clinic agree that in order to provide safe and effective care to opioid recipient
patients, changes are needed to support each individual and team to achieve success, in which the
care team has been given the resources in order to care for patients safely and effectively.
Evidence-based practice initiatives represent changes in practice that increase patient safety and
allow for providers to effectively care for their patients. The primary care office manager and
practice lead physician concur that it is important for the providers within the office to increase
evidence-based practice initiatives regarding care being delivered to opioid recipient patients,
especially in the midst of a state-wide crisis.
Weaknesses. Identified weaknesses related to providing safe and effective care to opioid
recipient patients include practice inconsistencies. There is one staff member in the office that
has already begun creating a new work flow process regarding practice changes required by law,
instead of waiting for official instruction from the opioid taskforce. It may be difficult for some
staff to accept new changes and to become consistent in both work flow and documentation.
Some providers and nursing staff may feel negatively towards change because its seen as
increasing their workload or making it more difficult to care for their patients. Some staff
members have reported that they believe these changes will make their work more stressful,
because patients who receive opioids are in distress over changes occurring with their care and
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express these concerns to staff. While the majority of the staff are receptive to change, even a
few staff members with negative attitudes represent a weakness within the primary care office.
Additionally, there are no systems in place to assess whether providers and staff are practicing
based on recommendations from the opioid taskforce, or whether they are practicing evidencebased care.
Opportunities. Opportunities identified for the primary care office include the attention the
opioid epidemic is receiving at the national and state levels. Nationally, President Trump has
declared the opioid crisis a national public health emergency under federal law and directed all
executive agencies to use all available resources to fight the opioid crisis (The White House,
United States Government, 2017). At the state level, politicians are equally concerned and have
passed new laws to help reduce prescription opioid abuse and decrease the number of deaths
related to opioid overdose (Michigan State Medical Society, 2018). At the organizational health
systems level, there is a group of physicians whom are part of the opioid taskforce that have been
appointed with guiding the outpatient settings through this practice change. The members of the
taskforce intend to provide the primary care offices with tools, resources, and policies related to
opioid prescription and the care of opioid recipient patients.
Threats. Threats to proposed practice change include negative attitudes held by opioid recipient
patients regarding satisfaction with their care. Many patients have voiced concern that they are
fearful they will no longer be given opioids for the treatment of chronic pain. Some patients have
called the office in anger and frustration in regard to recent changes in Michigan law. This in
turn causes staff to experience increased stress levels and feelings of resistance to change in
practice.
In addition, patients will be required to complete additional forms and consents and will
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be subject to random urine drug screens. Prescriptions may change or decrease depending on
how they are currently prescribed. All of these changes may result in dissatisfaction among this
patient population.
Clinical Practice Question
The identified clinical problem is related to opioid prescription and the standards of care
for opioid recipient patients. In order to solve this problem, a quality improvement intervention
must address the following clinical question: Are providers at the XXX primary care setting
utilizing evidence-based practice when caring for opioid recipient patients?
Review of the Literature
Method
A comprehensive electronic search was conducted in PubMed, CINAHL, and Web of
Science Core Collection and was limited to reviews in the English language during the period of
2014 to 2018. Keywords were drug monitoring, guideline, opioid, and primary care. Similar
search terms were used by utilizing Boolean operators (OR, AND) which effectively broadened
the search to include all relevant articles. The search yielded 332 articles. A total of nine
duplicates were found. Each review was screened using inclusion and exclusion criteria
(Appendix C). Review of titles and abstracts resulted in removal of 257 articles that did not meet
the inclusion criteria. Additionally, a total of 69 articles were excluded after further examination
of content, as they did not meet inclusion criteria. Many of the articles were reporting on the
same guidelines that were released through the United States Centers for Disease Control and
Prevention and were therefore excluded. The remaining six articles were included in this review.
The types of articles and study designs include case studies, pre and post intervention patient
cohorts, and a multi-pronged quality improvement project. Higher level evidence articles include
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critically appraised topics with evidence synthesis and guidelines, systematic review, and
prospective longitudinal controlled trial. While randomized controlled trials and evidence
reflecting the highest levels of research were desired, it was acknowledged that proper opioid
management may be a relatively new topic. Considering the 2017 announcement of the opioid
epidemic, applicable research may be currently occurring, and has not been published for review
and translation into practice.
PRISMA
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) is
an evidence-based set of items for reporting in systematic reviews and meta-analyses (Moher,
Liberati, Tetzlaff, & Altman, 2009). PRISMA focuses on the reporting of reviews evaluating
randomized control trials and is particularly useful when evaluating interventions (Moher et al.,
2009). The process utilizes a flow diagram that depicts the flow of information through the
different phases of the systematic review (Moher et al., 2009). The flow diagram maps out the
number of articles identified, which were included and excluded, and the reasons why certain
articles were excluded (Moher et al., 2009). The PRISMA flow diagram was utilized during the
literature review process for this project and provides meaningful understanding regarding how
the literature review was completed (Appendix C).
Summary of Results
Upon review of the six articles selected to be a part of the literature review, a table was
created to organize the information (Appendix D). Findings of this literature review highlight the
guidelines for opioid prescription, as reported by the CDC (Dowell et al., 2016). To gain better
understanding of how the guidelines operate and are utilized in the primary care setting, evidence
was reviewed, and it was determined that interventions exist that make guideline implementation
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more successful. Quality improvement projects have the propensity to enhance uptake of opioid
policies in primary care (Zgierska et al., 2018). In addition to guideline implementation, the
primary care provider must also become proficient in the management of patients with issues
related to opioid safety, efficacy, and misuse (Becker et al., 2016). Primary care practitioners
must also be equipped with strategies for preventing and managing aberrant opioid-related
behaviors (Argoff et al., 2014). Evidence supports that there are interventions that assist
providers with identifying patients at risk for misuse, increase provider confidence with opioid
prescription, and increase positive communication with pain specialists (Jamison et al., 2016).
Evidence to be used for Project
The results of the literature review suggest that current standards of care regarding opioid
prescription involve numerous activities that must be carried out by the prescriber. These
activities are aimed at patient safety. The following paragraphs will discuss these actions in
detail.
First and foremost, the patient should have a documented diagnosis of chronic pain,
including the source of the pain and any details pertaining to the diagnosis (Dowell et al., 2016).
This activity represents best practice and allows for improved intra-professional communication
(Dowell et al., 2016). According to the CDC, it is also important that the prescriber documents
morphine milligram equivalents per day in order to gain understanding of how much opioid the
patient is ingesting per day (Dowell et al., 2016). Higher amounts of morphine milligram
equivalents places the patient at a higher risk for overdose and death, and it is something the
provider needs to take into consideration (Dowell et al., 2016). Calculating the morphine
milligram equivalent essentially acts as a forewarning to the provider, allowing them to mitigate
risk by prescribing naloxone and providing education to the patient and their family (Dowell et
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al., 2016). Acknowledging concurrent benzodiazepine use is also evidence-based practice,
because it places the patient at risk for respiratory depression and accidental overdose (Dowell et
al., 2016). In addition, in alignment with evidence-based care, providers should be screening
patients with chronic pain for depression since this population is at a high risk for developing
concurrent depression (Zgierska et al., 2018). This can be achieved by using either the patient
health questionnaire-2 (PHQ-2) or patient health questionnaire-9 (PHQ-9).
In order to identify and remedy aberrant behaviors related to opioid abuse, there are
several evidence-based practice activities that prescribers should utilize. Providers should use
urine drug testing before starting opioid therapy and at least annually to assess for prescribed
medications, other controlled substances, and illicit drugs (Dowell et al., 2016).
Limitations of the literature review include the lack of high-level evidence, such as
systematic reviews or meta-analyses. Because the opioid epidemic has only recently been
declared a national crisis, high-level evidence in this arena simply has not been published.
Therefore, recommendations implemented in practice are derived from a report published by the
CDC (Dowell et al., 2016). It is clear that more research is needed to ensure safe practices
regarding opioid prescribing and management practices.
Phenomenon Conceptual Model
Conceptual models serve as guides in understanding a phenomenon and also guide
change initiatives within an organization. The Donabedian Model is a conceptual model that
evaluates main dimensions of health care quality (Donabedian, 1988). These three main
components include structure, process, and outcomes, and each component has a direct influence
on the next (Appendix E). Structure has an effect on process measures, which in turn affect
outcomes (Donabedian, 1988).
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Structure
According to the Donabedian Model, structure refers to the characteristics of personnel
who provide care to patients and the setting where care is being delivered (Donabedian, 1988).
Structure measures reflect the attributes of the provider and organizational characteristics
(Donabedian, 1988). In regard to this project, structure measures include use of electronic
medical records and the strong support from physicians and staff within the healthcare
organization. The physicians working within the opioid taskforce have initiated practice changes
that reflect new Michigan state laws for opioid prescription. These initiatives have led to changes
in the attitudes of the personnel providing care to patients, and all staff members are now aware
of the seriousness of the opioid epidemic. Organizational leaders are currently putting other
structures into place that embed certain aspects of care into the electronic health record,
including the signed consent form, treatment agreement form, and verification of checking
MAPS. However, the process for these structures being placed in the electronic health record
have been put on hold because the organization will be changing its electronic record system
within the next year.
Process
Process refers to all of the activities taking place while care is being delivered to the
patients (Donabedian, 1988). Process measures reflect the way a healthcare system processes
work to deliver desired outcomes (Donabedian, 1988). Examples include the length of time a
patient waits for their appointment, if patients are receiving certain standards of care, and if staff
are recording incidents that occur during a patient visit (Haj, Lamrini, & Rais, 2013). For this
project, process measures include whether patients are receiving evidence-based standards of
care, and whether these actions are integrated within care processes in tandem with proper
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documentation. This includes a documented urine drug screen, documented diagnosis of chronic
pain and the source of pain, documented concurrent benzodiazepine prescription, documented
depression screening, and documented morphine milligram equivalent.
Outcomes
Quality of care can be assessed in terms of outcome measures which include health status
indicators, as well as cost of care and patient satisfaction (Donabedian, 1988). Classic examples
of outcome measures include reduced mortality, reduced length of stay, reduced infection rates,
and improved patient experience (Haj et al., 2013). For this quality improvement project,
outcome measures include percentages of eligible adult patients with completed urine drug
screening, documented depression screening, documented concurrent benzodiazepine
prescription, documented diagnosis of chronic pain with source, and documented morphine
milligram equivalent.
Project Plan
This Doctor of Nursing Practice (DNP) project will be focused on assessing evidencebased care that is currently being delivered to adult opioid recipient patients. The quality
measures that have previously been discussed will be audited through the access of patient
charts. The results of the audit will be presented as percentages, depicting what percentage of
patients are receiving evidence-based care for each of the quality measures. The results of the
audit will be used to meet project goals, including development of a toolkit for continued
improvement and sustainability of quality measures, and may be used to guide future initiatives.
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Purpose of Project and Objectives
The purpose of this Doctor of Nursing Practice project is to implement a quality
improvement program for standards of care regarding adult opioid recipient patients in tandem
with designing an evidence-based toolkit for improvement and sustainment. This quality
improvement project will be implemented using the Plan-Do-Study-Act model and an applicable
toolkit.
Assessing the current state of evidence-based practice and improving upon the care being
delivered to opioid recipient patients will be attempted by the DNP student through the following
objectives:
•

Complete a gap analysis for opioid prescription evidence-based practice in the
primary care setting for adult patients receiving opioids by November 30th, 2018

•

Communicate findings with leaders, providers, and office staff by March 31st,
2019

•

Collaborate with leaders, providers, and office staff to design improvement and/or
sustainment strategies by January 2019

•

Design a toolkit with evidence-based improvement and sustainment
recommendations by January 2019

Design for the Evidence-based Initiative
This is a quality improvement project that will include a retrospective evaluation of
quality measures for evidence-based care being delivered to opioid recipient patients. After
determination and approval from both the health care organization and Grand Valley State
University institutional review boards, the Doctor of Nursing Practice student will perform chart
audits of adult patients receiving opioid prescriptions from the primary care clinic. This
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collection of data will begin November 2018 and will continue until April 2019. The data will be
analyzed using descriptive statistics, and results will be presented to office leaders, providers,
and staff for a collaborative discussion. Strategies for improvement and sustainment will be
developed. In addition, a toolkit will be designed that addresses the gaps previously identified in
the care being delivered to opioid recipient patients. The toolkit will also contain a checklist for
prescribing opioids for chronic pain, treatment alternatives for chronic pain, strategies for
minimizing opioid prescription abuse, and responding to aberrant drug-related behaviors.
Setting
The project will be conducted in a primary care office that is affiliated with a larger
health system. The health system is a non-profit healthcare organization that is part of a larger
multi-institutional Catholic health system (XXX, 2018). Within the West Michigan area, there
are a total of 33 primary care offices that are part of the healthcare system (XXX, 2018).
Services are provided to patients of all ages, with a strong focus on wellness and disease
prevention. The providers assess and treat patients for acute illness and chronic disease
management as well. The population they serve is not only diverse in age, but also in ethnicity
and culture. The Doctor of Nursing Practice student has secured administrative approvals to
conduct this quality improvement project from the health care organization (Appendix G) and
Grand Valley State University (Appendix H).
Participants
To be included in the analysis, patients must meet the following criteria: age
greater than or equal to 18 years old; active patient status (seen in the past three
years); have a primary care provider within this office; do not have a diagnosis of
malignant neoplasm or hospice status; and have at least one opioid prescription in
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the past 45 days that was not given for acute pain. Patients will be excluded if they
are younger than 18 years of age, have not been seen in the past three years, have a
diagnosis of malignant neoplasm or are currently hospice status, or have not been
given an opioid prescription in the last 45 days.
Model Guiding Implementation
The Plan-Do-Study-Act (PDSA) model is a four-stage problem-solving model that is
used to improve a process and carry out changes within an organization (Appendix F). The
PDSA model is typically used for small to medium scaled quality improvement projects
(Institute for Healthcare Improvement, 2018). Improving quality means making healthcare safer,
more efficient, patient centered, effective, and equitable (Donnelly & Kirk, 2015).
Plan. The first step of the planning stage is to assemble a team that has knowledge of the
problem (Institute for Healthcare Improvement, 2018). Roles and responsibilities need to be
identified, timelines must be set, and a meeting schedule must be established (Institute for
Healthcare Improvement, 2018). Next, an aim statement should be made, which states what is
trying to be accomplished and what changes can be made to improve the situation (Institute for
Healthcare Improvement, 2018). Current process needs to be examined by completing a
strengths, weakness, opportunities, and threats (SWOT) analysis (Institute for Healthcare
Improvement, 2018). After the SWOT analysis is completed, a problem statement must be
written to clearly summarize the problem (Institute for Healthcare Improvement, 2018). Lastly,
an action plan needs to be developed that includes necessary resources and a timeline (Institute
for Healthcare Improvement, 2018).
Do. The second step is to implement the action plan that was developed in step one. Data
collection occurs during this step from a particular point in time and is measured over a period of
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time in order to record patterns in the data (Donnelly & Kirk, 2015). The investigator should also
document problems, unexpected findings, and general observations (Institute for Healthcare
Improvement, 2018).
Study. The third step of the process is to use the aim statement from step one and the
data gathered in step two in order to determine results and trends in the data (Institute for
Healthcare Improvement, 2018). This involves studying and analyzing the data and the process
itself (Donnelly & Kirk, 2015). To facilitate seeing trends in data, descriptive statistics can be
used to present the data in a meaningful way. Information can be displayed in graphs and charts
for ease of use.
Act. The fourth step of the process is to determine whether the plan resulted in success,
or whether the process needs to be re-examined (Institute for Healthcare Improvement, 2018).
Accomplishments from the project should be communicated to appropriate personnel and steps
to preserve gains and sustain accomplishments should be taken (Institute for Healthcare
Improvement, 2018). Lastly, the project should be documented and what was learned from the
process must be clearly expressed (Donnelly & Kirk, 2015).
According to current evidence, standards of care for opioid recipient patients were
identified and recommendations were published for primary care providers as a guide (Dowell et
al., 2016). Current literature also provides evidence that providing health care providers with
educational interventions, such as toolkits, can positively impact the care they provide to their
patients (Zgierska et al., 2018). In order to complete this quality improvement project, the Doctor
of Nursing Practice student will use the PDSA model as a guide for implementation, which will
be discussed in the following sections.
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Implementation Steps and Strategies
This quality improvement project will be implemented at a primary care clinic. Project
procedures will occur tentatively between November 5, 2018-April 1, 2019. The project steps
are as follows:
1. The Doctor of Nursing Practice student will perform chart audits at the primary care
clinic on a monthly basis between November 2018 until April 2019, and data will be
collected for evidence-based quality measures including the following:
a. Documented urine drug screening (at least annually)
b. Documented diagnosis of chronic pain and source of pain
c. Documented concurrent benzodiazepine prescription
d. Documented depression screening (PHQ 2 or PHQ 9)
e. Documented morphine milligram equivalent (MME)
2. The Doctor of Nursing Practice student will collaborate with information technology
personnel in order to obtain reports that address the evidence-based quality measures
outlined in step one. This will be completed by January 31, 2019.
3. The Doctor of Nursing Practice student will assess the use of evidence-based practice
guidelines by analyzing the gathered data using descriptive statistics. This will include
a consultation with a statistician. Graphs and pie charts will be utilized in order to
present the information in a meaningful way. This will be completed by March 31,
2019.
4. The Doctor of Nursing Practice student will communicate findings with leaders,
providers, and office staff by April 30, 2019. Results of chart reviews, including
statistics and outcomes reflecting quality improvement initiatives will be presented to
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providers at the primary care office that shows collective results of the following
quality measures:
a. Percent of eligible adult patients with urine drug screening completed
b. Percent of eligible adult patients with documented screening using PHQ 2 or
PHQ9 depression screening tool
c. Percent of eligible adult patients with documented concurrent benzodiazepine
prescription
d. Percent of eligible adult patients with documented diagnosis of chronic pain
and source of pain
e. Percent of eligible adult patients with documented morphine milligram
equivalent (MME)
5. The Doctor of Nursing Practice student will collaborate with leaders, providers and
office staff to design improvement strategies that reflect organizational goals and
sustainment strategies. This will be completed by February 28, 2019.
6. The Doctor of Nursing Practice student will develop a toolkit with evidence-based
improvement and sustainment recommendations. The content of the toolkit will be
based upon results obtained during data collection and data analysis. This will be
completed by March 31, 2019.
7. The Doctor of Nursing Practice student will share recommendations for improvement
of quality measures with leaders, providers and office staff by April 30, 2019.
8. The Doctor of Nursing Practice student will deliver an evidence-based toolkit to
organizational leaders, providers and office staff by April 30, 2019. The toolkit content
will entail the following at minimum:
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a. Checklist for prescribing opioids for chronic pain
b. Treatment alternatives for chronic pain
c. Strategies for minimizing opioid prescription abuse and responding to aberrant
drug-related behaviors
9. The Doctor of Nursing Practice student will ensure a sustainment plan is in place that
includes the following:
a. The identification of a staff member within the organization to monitor quality
indicators after the student has finished the project by April 30, 2019.
b. The organization will be presented with a toolkit for future use in practice,
which will act as guide for everyday practice by April 30, 2019.
Measures
The first indicator to be assessed is whether the clinical question was able to be answered
through the completion of a gap analysis for opioid prescription in the primary care setting. Data
obtained from chart review and reports obtained through the assistance of information
technology personnel will be analyzed by the Doctor of Nursing Practice student with the
assistance of a statistician. The data will be presented through descriptive statistics and will be
utilized in determining the answer to the previously stated clinical question.
The next indicator to be assessed includes whether findings were able to be
communicated with leaders, providers and office staff. This will be achieved during a monthly
staff meeting in March 2019. This will require collaboration with, along with approval from the
office manager.
Lastly, indicators include whether an evidence-based toolkit was designed through
collaboration with leaders, providers and office staff that includes improvement and sustainment
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recommendations. The Doctor of Nursing Practice student will develop the toolkit based on
needs identified during data analysis. The toolkit will be tailored to address measures that were
found to be less than satisfactory.
Data Collection Procedures
The data collection will be conducted by the Doctor of Nursing Practice student. The data
will be collected from two separate timeframes, which will be June 1st, 2018, to September 30th,
2018, and October 1st, 2018, to January 31st, 2019. All data collection will take place onsite at the
primary care office and will occur between November 5th, 2018 and April 1st, 2019. The data will
be collected from electronic health records of patients that fit the specified criteria. Again, this
will include documentation of a urine drug screen, documentation of depression screening,
documentation of morphine milligram equivalents, documentation of chronic pain diagnosis with
source of pain, and documented concurrent benzodiazepine use. At this time, the sample size is
not known. For this quality improvement project, an instrument will not be used for data
collection, such as a questionnaire. Instead, the data will be collected during chart audits. The
data collected from the patient charts by the Doctor of Nursing Practice student will be entered
into a spreadsheet that can later be used for analysis by a consulting statistician.
Data Management
The Doctor of Nursing Practice student will be responsible for data management. The
data will be generated through chart audits conducted by the Doctor of Nursing Practice
student and entered into a spread sheet. The student will also consult with information
technology personnel to obtain aggregate data. At this point, it has not been determined which
measurements are capable of being pulled through reports generated by information
technology personnel within the organization. There will be no identifiable data. Only project
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team members and the consulting statistician will have access to the data and use it for
completion of this project. All study records and data will be kept and accessible for a
minimum of seven years, as required by the healthcare organization.
Analysis
Summary/descriptive statistics will be used to summarize the data in a meaningful way,
allowing for simpler interpretation of the data. Frequency and percentage statistics will be
utilized to present the data. The analysis will be completed by the Doctor of Nursing Practice
student and a Grand Valley State University statistician. The data will be displayed using graphs,
tables, and pie charts. Using the graphs, tables, and pie charts will allow the Doctor of Nursing
Practice student to identify which measures will require the greatest amount of educational
material to be presented in the toolkit. For example, if the majority of patients do not have a
documented urine drug screen, there will be an educational element within the toolkit that
addresses strategies to improve that quality measure.
Resources & Budget
The financial operating plan for this quality improvement project includes an
evaluation of revenue and expenses (Appendix I). Expenses for this project include
time and resources required of the Doctor of Nursing Practice student to gather data
from patient charts, develop educational and toolkit materials, and implement
education to the providers, leaders, and staff within the primary care office. The
largest cost for this project is the time that the Doctor of Nursing Practice student is
providing to the organization. This donation of time by the Doctor of Nursing
Practice student will be made in an in-kind donation. The project site mentor and
primary care office manager will also be providing an in-kind donation of time to the
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organization by assisting the student with the project. Other costs of the project
include consultations with a statistician and information technology staff. Additional
costs also include laptop, the cost of occupying office space, and the cost of printed
education and toolkit material.
The budget table displays data in both the expenses and revenue columns that
are similar. This was done intentionally to show that the time and resources needed
to support this quality improvement project were donated and can be considered
revenue. However, if the staff were removed from their regular practices to
participate in a meeting specific to the project, there is an expense for their time. The
presentation of project findings and subsequent educational session will be
completed during a staff meeting, therefore no additional costs for reimbursing staff
will be incurred. However, it is important to consider the cost for their time, as there
are six physicians, two nurse practitioners, and one physician assistant that will be
present at the provider meeting. The average hourly wage for a primary care
physician is $100 (Salary.com, 2018a). The average hourly wage for primary care
nurse practitioners is $48 (Salary.com, 2018b). The site mentor for the project is a
nurse practitioner, and it is estimated that she will spend an additional 30 hours
working on the project in collaboration with the Doctor of Nursing Practice student.
The average hourly wage for a primary care physician assistant is also $48
(Salary.com, 2018c). The office manager, and two staff lead registered nurses will
also be present at the meeting. The average hourly wage for the office manager is
$30 (Payscale.com) and her estimated time spent contributing to the project is 15
hours. The average hourly wage for registered nurses is $26 (Payscale.com, 2018b).

31
PROPOSAL DEFENSE

Consultations for the project will include a statistician and information
technology personnel. It is estimated that the statistician will spend 6 hours
analyzing data and producing meaningful descriptive statistics, with an average
hourly wage of $50 (Salary.com, 2018d). It is estimated that information technology
personnel will spend 5 hours complying reports for the project, with an average
hourly wage of $32 (Salary.com, 2018e).
To mitigate costs incurred, it is important to consider the costs associated
with risks of not implementing this project. This includes the value placed on human
life and patient safety. Standards of care regarding opioid prescription as described
in the literature strive to save lives by helping providers practice in a way that
decreases risk of opioid overdose, whether it be intentional or accidental.
Timeline
Project planning began spring of 2018 with the completion of a project
prospectus. During summer of 2018, an organizational assessment and literature
review were completed. During fall of 2018, project planning continued, and
documents were submitted to the healthcare organization’s institutional review
board and Grand Valley State University’s institutional review board. The student
will make a formal project presentation November 5th, 2018 that outlines the project
for project members and advisors. The project work will take place between
November 5th, 2018 and April 1, 2019. Data collection will take place between
November 5th, 2018 and January 31st, 2018. After data collection is completed in
January 2018, the student will compile the results and present them to the healthcare
organization and Grand Valley State University team members in a final project
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defense.
Sustainability Plan
Sustainability is a vital piece to include when planning and implementing a
quality improvement project. If a sustainability plan is not part of the project, the
staff of the organization may find themselves repeatedly solving the same problems.
In an effort to promote sustainability, the sustainability plan will address two
categories which include staff and process. The sustainability plan for this project
includes the identification of a staff member within the organization to monitor
quality indicators. It is important that this individual is someone that is invested in
the organization and is passionate about improving quality of care and patient safety.
This could potentially be the practice lead physician or the office manager. In order
to promote sustainability at a process level, the organization will be presented with a
toolkit for future use in practice. By providing a toolkit, the providers and staff
members will have access to resources that positively impact the care they provide.

33
PROPOSAL DEFENSE

References
Allen, B. (2016). Effective design, implementation and management of change in healthcare. Nursing
Standard, 31(3), 58. doi:http://dx.doi.org.ezproxy.gvsu.edu/10.7748/ns.2016.e10375
Argoff, C. E., Kahan, M., & Sellers, E. M. (2014). Preventing and managing aberrant drug-related
behavior in primary care: systematic review of outcomes evidence. Journal of Opioid
Management, 10(2), 119–134. https://doi.org/10.5055/jom.2014.0201
Becker, W. C., Merlin, J. S., Manhapra, A., & Edens, E. L. (2016). Management of patients with
issues related to opioid safety, efficacy and/or misuse: a case series from an integrated,
interdisciplinary clinic. Addiction Science & Clinical Practice, 11, 3.
https://doi.org/10.1186/s13722-016-0050-0
Burke, W., & Litwin, G. (1992). A causal model of organizational performance and change. Journal
of Management, 18(3), 523-545. doi:10.1177/014920639201800306
Centers for Disease Control and Prevention. (2016). Prescription opioids: What you need to
know. Retrieved from https://www.cdc.gov/drugoverdose/pdf/aha-patient-opioid-factsheet-a.pdf
Centers for Disease Control and Prevention. (2017). Opioid overdose. Retrieved from
https://www.cdc.gov/drugoverdose/index.html
Chen, J. H., Hom, J., Richman, I., Asch, S. M., Podchiyska, T., & Johansen, N. A. (2016). Effect of
opioid prescribing guidelines in primary care. Medicine, 95(35), e4760.
https://doi.org/10.1097/MD.0000000000004760
Donnelly, P., & Kirk, P. (2015). Use the PDSA model for effective change management. Education
for Primary Care, 26, 279-281.

34
PROPOSAL DEFENSE

Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC Guideline for Prescribing Opioids for
Chronic Pain--United States, 2016. JAMA, 315(15), 1624–1645.
https://doi.org/10.1001/jama.2016.1464
Haj, H. I., Lamrini, M., & Rais, N. (2013). Quality of care between Donabedian Model and
ISO9001V2008. International Journal for Quality Research, 7(1), 17-30.
Institute for Healthcare Improvement. (2018). How to improve. Retrieved from
http://www.ihi.org/resources/Pages/HowtoImprove/default.aspx
Jamison, R. N., Scanlan, E., Matthews, M. L., Jurcik, D. C., & Ross, E. L. (2016). Attitudes of
Primary Care Practitioners in Managing Chronic Pain Patients Prescribed Opioids for Pain: A
Prospective Longitudinal Controlled Trial. Pain Medicine, 17(1), 99–113.
https://doi.org/10.1111/pme.12871
Michigan Academy of Physician Assistants. (2018). Opioid alert: New prescribing requirements.
Retrieved from http://www.michiganpa.org/news/385207/Opioid-Alert---New-PrescribingRequirements.htm
Michigan State Medical Society. (2018). Reversing the Opioid Epidemic. Retrieved from
https://www.msms.org/Resources/Quality-Patient-Safety/Reversing-the-Opioid-Epidemic
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic
reviews and meta-analyses: The PRISMA statement. BMJ, 339. doi:10.1136/bmj.b2535
Payscale.com (2018a). Average Medical Office Manager Salary. Retrieved from
https://www.payscale.com/research/US/Job=Medical_Office_Manager/Salary

35
PROPOSAL DEFENSE

Payscale.com (2018b). Average Primary Care Registered Nurse Hourly Pay. Retrieved from
https://www.payscale.com/research/US/Job=Primary_Care_Registered_Nurse_(RN)/Hourly_Rat
e
Salary.com (2018a). Physician- Family Practice in Michigan. Retrieved from
https://www1.salary.com/MI/family-physician-salary.html
Salary.com (2018b). Nurse Practitioner in Michigan. Retrieved from
https://www1.salary.com/MI/Nurse-Practitioner-salary.html
Salary.com (2018c). Physician Assistant- Medical in Michigan. Retrieved from
https://www1.salary.com/MI/Physician-Assistant-Medical-salary.html
Salary.com (2018d). Hourly Wage for Statistician in the United States. Retrieved from
https://www1.salary.com/Statistician-V-hourly-wages.html
White House, United States Government. (2017). The Opioid Crisis. Retrieved from
https://www.whitehouse.gov/opioids/
World Health Organization (2008). Stakeholder Involvement. Retrieved from
http://www.who.int/dietphysicalactivity/griffiths-stakeholder-involvement.pdf
XXX. (2018). XXX Health system, a member of XXX health. Retrieved from
https://www.mercyhealth.org/about/trinity-health/
Zgierska, A. E., Vidaver, R. M., Smith, P., Ales, M. W., Nisbet, K., Boss, D., … Hahn, D. L. (2018).
Enhancing system-wide implementation of opioid prescribing guidelines in primary care:
protocol for a stepped-wedge quality improvement project. Bmc Health Services Research, 18,
415.

36
PROPOSAL DEFENSE

Appendix A
The Burke-Litwin Model

A Model of Organizational Performance and Change. Burke, W. W., & Litwin, G. H. (1992). A
causal model of organizational performance and change. Journal of Management, 18(3),
523-545.
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Appendix B
SWOT Analysis
Strengths

•
•
•
•
•
•
•

Weaknesses

•
Support of larger health care system
Positive culture within setting,
motivated to keep patients safe
Management and practice lead buy in
Strong working relationships
Strong leadership
Strong emphasis on evidence-based
practices
Current initiatives that address care
processes regarding opioid
prescription

•
•

Opportunities

•
•
•

US government has declared the
opioid crisis a national public
emergency
New state laws regarding opioids to
combat the opioid epidemic
Organizational opioid taskforce

Negative attitudes within the primary
care office among some individuals
Practices vary within the
organization’s primary care offices
Currently no system in place to
evaluate current practices regarding
care of opioid recipient patients

Threats

•
•
•

Negative attitudes and beliefs held by
some opioid recipient patients
Negative attitudes and beliefs held by
some staff members
Electronic health system changes
occurring in the near future prohibit
growth within current electronic
system
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Appendix C
Flow Diagram
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Appendix D
Table of Evidence
Author (Year), Title,
Purpose
Argoff, C. E., Kahan, M., &
Sellers, E. M. (2014).
Preventing and managing
aberrant drug-related behavior
in primary care: systematic
review of outcomes evidence.
Purpose: To review evaluated
data supporting basic strategies
for addressing aberrant opioidrelated behaviors.

Design (N)
Systematic
Review

Becker, W. C., Merlin, J. S., Case studies
Manhapra, A., & Edens, E. L. (Series of 3)
(2016). Management of patients
with issues related to opioid
safety, efficacy and/or misuse: a

Intervention/
Methods
PubMed was
searched using 9
general headings
related to
minimizing
opioid abuse risk
and addressing
aberrant drugrelated behavior.

The authors
present three
cases referred to
their primary
care clinic that
highlight

Results

Conclusion

Nine distinct strategies for
minimizing abuse and responding
to aberrant drug-related behaviors
were identified and discussed.

Weak to
moderate evidence suppor
ts the value of thorough
patient assessment, riskscreening tools,
controlled-substance
agreements, careful dose
titration, opioid dose
ceilings, compliance
monitoring, and
adherence to practice
guidelines. Moderate to
strong evidence suggests
that prescribing tamperresistant opioids may help
prevent misuse but may
also have the unintended
consequence of
prompting a migration of
users to other marketed
opioids, heroin, or other
substances.
The three cases represent
common challenges at the
intersection between
chronic pain and opioid
safety, efficacy and
misuse.

With respect to assessment, the
cases represent making the
diagnosis of opioid use disorder,
allowing the patient space,
identification of co-occurring
hazardous alcohol use, and
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case series from an integrated,
interdisciplinary clinic.
Purpose: To improve the
quality of care of patients with
co-occurring chronic pain and
issues related to opioid safety,
efficacy and/or misuse.

complex clinical
scenarios.

Chen, J. H., Hom, J., Richamn, Pre and post
I., Asch, S. M., Podchiyska, T., intervention
& Johansen, N. A. (2016).
patient
cohorts
Effect of opioid prescribing (N=119)
guidelines in primary care.
Purpose:
Assemble
comprehensive guidelines for
chronic opioid prescribing,
including
monitoring
and
referral
recommendations.
Disseminate guidelines in
primary care.

Guidelines were
disseminated
through
presentation at
mandatory
meetings and email distribution.
Pre and post
intervention
evaluation
periods to
identify changes
in patient and
provider
behaviors.
CDC developed
the guideline
using the
Grading of
Recommendatio
ns Assessment,
Development,

Dowell, D., Haegerich, T. M, &
Chou, R. (2016).
CDC Guideline for Prescribing
Opioids for Chronic PainUnited States, 2016. Purpose:
To report guidelines from CDC
that addresses 1) when to

Critically
appraised
topicEvidence
synthesis
and
guidelines

recognizing barriers to multimodal
pain care. With respect to
treatment, the cases represent
changes in treatment with which
the patient may not agree,
effectiveness of
buprenorphine/naloxone for
treatments of chronic pain and
making continued opioid therapy
contingent on engagement with
substance abuse treatment.
After disseminating guidelines, the
percentage of noncancer clinic
patients receiving any opioid Rxs
dropped from 3.9% to 3.4%
(P = 0.02). The percentage of
noncancer patients receiving
chronic opioid Rxs decreased from
2.0% to 1.6% (P = 0.03). The rate
of urine drug screening increased
from 9.2% to 17.3% (P = 0.005)
amongst noncancer chronic opioid
patients.

Guidelines for prescribing opioids
for chronic pain were created, as
well as a checklist that providers
can use when prescribing opioids
for chronic pain. Checklist:
http://stacks.cdc.gov/view/cdc/380
25

An educational
intervention for opioid
prescribing in a general
primary care setting is
feasible and may be
expected to modestly
reduce overall opioid Rx
rates and increase
provider use of systematic
monitoring methods.

This guideline is intended
to improve
communication between
clinicians and patients
about the risks and
benefits of opioid therapy
for chronic pain, improve
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initiate or
continue opioids for chronic pai
n; 2) opioid selection, dosage,
duration, follow-up, and
discontinuation; and 3)
assessing risk and addressing
harms of opioid use.

Jamison, R. N., Scanlan, E.,
Matthews, M. L., Jurcik, D. C.,
& Ross E. L. (2016).
Attitudes of primary care
practitioners
in
managing
chronic pain patients prescribed
opioids for pain: A prospective
longitudinal controlled trial.
Purpose: To help determine
whether patient risk assessment
and
incorporation
of
a
structured
opioid
therapy
protocol of monthly monitoring
and compliance checklists
would improve practitioner
confidence
in
managing
challenging
chronic
pain
patients within a busy primary
care center.

Prospective
longitudinal
controlled
trial (N=56
PCPS,
N=253
patients)

and Evaluation
(GRADE)
framework, and
recommendation
s were made on
the basis of a
systematic
review of the
scientific
evidence.
The
following
measures were
administered to
each
of
the
primary
care
participants:
background and
prescribing
practices
questionnaire,
general
health
questionnaire,
opioid therapy
survey, concerns
about analgesic
prescriptions,
and test of opioid
knowledge.
The following
measures were
administered to
each of the
patients that

the safety and
effectiveness of pain
treatment, and reduce the
risks associated with
long-term opioid therapy,
including opioid use
disorder, overdose, and
death.

After 1 year all the PCPs reported
improvement in identifying
patients at risk for misuse
(P<0.05), perceived confidence in
prescribing opioids for pain
(P<0.05), and increased
satisfaction with communication
with pain specialists (P<0.05). The
patients reported greater
compliance with their opioid
medication and felt that the
monthly monitoring was
beneficial.

The results of this study
demonstrated
improvement in the
number of practitioners
who could identify
patients at risk for misuse,
were satisfied with
communication are the
center, and felt
sufficiently trained in
opioid prescribing.
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Zgierska, A. E., Vidaver, R. M.,
Smith, P., Ales, M. W., &
Nisbet, K. (2018).
Enhancing
system-wide
implementation
of
opioid
prescribing
guidelines
in
primary care: protocol for a
stepped-wedge
quality
improvement project.
Purpose: The goal of this
quality improvement (QI)
project is to assess whether a
clinic-tailored QI intervention
improves the implementation

Multipronged
quality
improveme
nt
intervention

participated:
demographic
questionnaire,
the brief pain
inventory, pain
catastrophizing
scale, the pain
disability index,
the hospital
anxiety and
depression scale,
screener and
opioid
assessment for
pain patientsrevised, and the
opioid
compliance
checklist.
A health system
with 28 primary
care clinics
caring for
approximately
294,000 primary
care patients
developed and
implemented a
guideline driven
policy on longterm opioid
therapy in adults
with opioid

The authors hypothesize that the
addition of this intervention will
enhance implementation of
guideline-driven recommendations
in primary care.

Developing methods for a
health system-tailored QI
intervention required a
multi-step process to
incorporate end-user
feedback and account for
the needs of targeted
clinic team members.
Delivery of such tailored
QI interventions can
enhance uptake of opioid
policies in primary care.
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of a health system-wide,
guideline-driven policy on
opioid prescribing in primary
care.

treated chronic
pain. The QI
intervention
included clinicwide and
individual
clinician-level
educational
interventions. To
evaluate the
impact of the QI
intervention, the
team collected
two main types
of date before,
during, and after
intervention: a)
EHR-based
clinic-level data
on elements of
the health
system’s opioid
policy; and b)
process measures
from the clinical
staff, and project
team
experiences, and
perceptions
related to the QI
intervention
implementation.

44
Running head: PROPOSAL DEFENSE

Appendix E
Donabedian Model

Donabeidan, A. (1988). The quality of care: how can it be assessed? JAMA, 260, 1743-1748.
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Appendix F
Plan Do Study Act Model

Plan Do Study Act Model. Langley, G. J., Moen, R. D., Nolan, K. M., Nolan, T. W., Norman, C.
L., & Provost, L. P. (2009). The improvement guide: A practical approach to enhancing
organizational performance, 2nd edition. San Francisco, CA: Jossey-Bass. Used with permission
from Wiley publishing.
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Appendix G
Health Care Organization Internal Review Board Determination Letter
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Appendix H
Grand Valley State University Internal Review Board Determination Letter
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Appendix I
Budget for Project
Project Financial Operating Plan
Standards of Care for Opioid Recipient Patients
Revenue
Project Manager Time (in-kind donation)
Team Member Time:
Site Mentor Time (in-kind donation)
Primary Care Office Manager
6 Physicians (1 hour staff meeting)
1 Physician Assistant (1 hour staff meeting)
2 Registered Nurses (1 hour staff meeting)
2 Nurse Practitioners (1 hour staff meeting)
Consultations:
Statistician
IT staff
Cost of space
TOTAL INCOME
Expenses
Project Manager Time (in-kind donation)
Team Member Time:
Site Mentor Time (in-kind donation)
Primary Care Office Manager
6 Physicians (1 hour staff meeting)
1 Physician Assistant (1 hour staff meeting)
2 Registered Nurses (1 hour staff meeting)
2 Nurse Practitioners (1 hour staff meeting)
Consultations:
Statistician
IT staff
Laptop
Cost of space
Cost of printed education and toolkit material
TOTAL EXPENSES
OPERATING INCOME

9,000.00
1,440.00
450.00
600.00
48.00
52.00
90.00
300.00
160.00
800.00
12,940.00

9,000.00
1,440.00
450.00
600.00
48.00
52.00
90.00
300.00
160.00
800.00
800.00
40.00
13,780.00
-840.00
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Appendix J
Approval of Use for Burke-Litwin Model
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Appendix K
Approval of Use for Donabedian Model
*Awaiting
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Appendix L
Approval for Use of Plan Do Study Act Model

